|
|
 |
|
Viewing report
|
|
|
|
European Bone and Joint Health Ingredients Market
Frost & Sullivan, March 2009, Pages: 93
This research investigates the European Bone and Joint Health ingredients market from 2005 to 2008, with forecasts to 2015. It offers a comprehensive insight to the European Bone and Joint Health ingredients market, its structure and developments related to it. It clearly lists and defines the market drivers and restraints that have had an impact in the European scenario.
This Frost & Sullivan research service titled European Bone and Joint Health Ingredients Market provides an analysis on bone and joint health ingredients from 2005 to 2015. Geographically, this research service covers the market in Europe. In this research, Frost & Sullivan's expert analysts thoroughly examine the following markets: calcium and vitamin D, prebiotic fibre, soyisoflavone, glucosamine, chondroitin and other ingredients.
Consumers’ Preference for Preventive Measures Due to Spiralling Healthcare Costs Drives the European Bone and Joint Health Ingredients Market
With the growing incidence of osteoporosis and consumers’ increasing partiality to preventive care in order to avoid prohibitive healthcare costs, several food and ingredient manufacturers are realigning their business to focus on the health market. The ability of bone and joint health ingredients to alleviate bone and joint-related diseases, along with the rising consumer preference for condition-specific nutrition, has significantly enhanced the growth of this market in Europe. 'Calcium is the most widely recognized and used ingredient for imparting bone health benefits, while glucosamine and chondroitin constitute the ingredients with the largest application for joint health,' say the analysts of this research.
A large number of bone health products are targeted at menopausal women and the elderly; however, it has been found that men and women of all ages and ethnicities could develop osteoporosis. The need for bone and joint supplements for children and men as well considerably expands the scope of the market. Additionally, greater emphasis on prevention and management of chronic diseases related to aging would have a favourable impact on the growth of the bone and joint health ingredients market.
Despite the benefits of bone and joint health ingredients, the growing concern for other ailments such as cancer, obesity and heart health undermines the importance of bone and joint health, as it is perceived to be nonfatal. 'Apart from this status as a non-vital ingredient, manufacturers will also have to deal with the stiff competition from Asian participants in certain segments such as glucosamine and chondroitin,' notes the analyst. 'Additionally, European manufacturers’ inability to match the lower prices offered by the Asian participants coupled with legislative changes is adversely affecting profits and market penetration.' European manufacturers are making efforts to offset competition from their low-cost Asian counterparts by emphasising on innovations, superior customer service, quality and expertise.
Product samples
A sample for this product is available. Please Login/Register to download this sample.
Customers who bought this item also bought
U.S. Prebiotics Markets
The Future of High Potency Active Pharmaceutical Ingredients (HPAPIs), Market Forecasts and Growth Opportunities to 2015 - Growing Demand Drives Investment in Capacity
European Women's Healthcare Imaging Markets
European Cancer IVD Market
European Natural Extracts Markets
U.S. Digestive Health Ingredients Markets
Bone and Joint Infection Market to 2016 - Medical Imaging and PCR Methods to Facilitate Early Diagnosis and Treatment
European HIV/AIDS and Hepatitis B/C Molecular Diagnostics Market
Asia Pacific Cognitive Health Ingredients in Human Nutrition
Europe CoenzymeQ10 Markets
|
|
|
|
